New England IRB (acquired by WCG IRB) Employee Directory
Pharmaceutical ManufacturingUnited States11-50 Employees
New England IRB is a central independent review board for sponsors, CROs and individual researchers across North America. Our priority is to ensure the safety of human subjects in clinical trials, and we are committed to an ethical and thorough review process.
New England IRB reviews:
All Phases of FDA regulated clinical trials:
Phase I - IV
Phase I/IIa hybrid studies
Patient reported outcomes studies
Drug, device and biologic studies (including vaccine studies)
Registry studies
Peri-approval and post-approval studies
Socio-behavioral and educational studies
Requests for Exemption